O
Omeros Corporation (OMER)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
$13.92
-2.76 (-16.55%)
Market Cap: $1.21B
Last updated: Nov 17, 2026 at 4:36 PM ET
Omeros Corporation (OMER) P/E Ratio & Valuation Multiples
Omeros (OMER) trades at 134.4x trailing earnings and 13.7x sales. Its forward P/E is 16.5x.
Current Multiples
Its forward P/E on consensus earnings for the next fiscal year to be reported is below its trailing P/E. Consensus earnings per share are about 714.5% higher than over the last four quarters.
| Multiple | Value |
|---|---|
| P/E (trailing) | 134.4x |
| Forward P/E | 16.5x |
| Price to sales | 13.7x |
| PEG | N/A |
| FCF yield | -3.6% |
Valuation History
Over the 5 of the 10 year ends shown that have a P/S, its P/S ranged from 9.7x in 2016 to 308.9x in 2019.
| Year end | Price | P/S | P/B |
|---|---|---|---|
| 2025 | $17.18 | N/A | N/A |
| 2024 | $9.88 | N/A | N/A |
| 2023 | $3.27 | N/A | N/A |
| 2022 | $2.26 | N/A | 1.7x |
| 2021 | $6.43 | N/A | 16.9x |
| 2020 | $14.29 | 135.5x | N/A |
| 2019 | $14.09 | 308.9x | N/A |
| 2018 | $11.14 | 18.2x | 0.8x |
| 2017 | $19.43 | 13.6x | N/A |
| 2016 | $9.92 | 9.7x | N/A |
Frequently Asked Questions About OMER
What is OMER's forward P/E ratio?
Omeros has a forward P/E ratio of 16.5x.
What is OMER's price to sales ratio?
Omeros has a price to sales ratio of 13.7x.
OMER pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors